SPIA
XBIO icon

Steward Partners Investment Advisory’s Xenetic Biosciences XBIO Stock Holding History

Steward Partners Investment Advisory’s Portfolio XBIO Stock Details XBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,900
Closed -$7.16K – 3730
2024
Q1 		$7.16K Hold
1,900
– – ﹤0.01% 2930
2023
Q4 		$6.55K Hold
1,900
– – ﹤0.01% 2863
2023
Q3 		$9.31K Hold
1,900
– – ﹤0.01% 2628
2023
Q2 		$6.23K Hold
1,900
– – ﹤0.01% 2725
2023
Q1 		$7.71K Hold
1,900
– – ﹤0.01% 2639
2022
Q4 		$5.42K Hold
1,900
– – ﹤0.01% 2747
2022
Q3 		$10K Hold
1,900
– – ﹤0.01% 2552
2022
Q2 		$15K Hold
1,900
– – ﹤0.01% 2361
2022
Q1 		$19K Hold
1,900
– – ﹤0.01% 2404
2021
Q4 		$25K Buy
+1,900
New +$30.3K ﹤0.01% 2233
2021
Q3 		– Sell
-2,500
Closed -$51K – 3360
2021
Q2 		$51K Hold
2,500
– – ﹤0.01% 3357
2021
Q1 		$54.5K Buy
+2,500
New +$65.8K ﹤0.01% 1937

Other funds holding XBIO

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Steward Partners Investment Advisory's XBIO Position: Q2 2024 in Review

Steward Partners Investment Advisory sold out of Xenetic Biosciences (XBIO) in Q2 2024, closing a stake of 1,900 shares — an estimated $7.16K sold.

Steward Partners Investment Advisory first reported a position in XBIO in Q1 2021 and held it in 12 quarters. The position peaked at $54.5K in Q1 2021. 5 funds tracked by Wall St. Rank hold XBIO as of Q2 2024.

  • Steward Partners Investment Advisory reported no remaining Xenetic Biosciences position as of Q2 2024 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 1,900 Xenetic Biosciences shares in Q2 2024, an estimated $7.16K.
  • Steward Partners Investment Advisory first reported a position in Xenetic Biosciences in Q1 2021 and held it in 12 quarters.
  • Steward Partners Investment Advisory's Xenetic Biosciences position peaked at $54.5K in Q1 2021.
  • 5 funds tracked by Wall St. Rank held Xenetic Biosciences as of Q2 2024.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2024, filed 8 Aug 2024.